The American Society of Gene & Cell Therapy (ASGCT) Annual Meeting will bring together scientists, clinicians, industry leaders, and innovators to explore the latest breakthroughs shaping the field. The conference features a robust program of scientific sessions, keynote presentations, and networking opportunities designed to showcase cutting-edge research, emerging technologies, and clinical advancements. As the largest and most comprehensive meeting of its kind, ASGCT provides a unique platform for collaboration, knowledge sharing, and partnership across the industry, making it a must-attend event for those advancing next-generation therapies.

Date: May 11-15, 2026
Location: Thomas M. Menino Convention & Exhibition Center, Boston, Massachusetts
Booth: #1249

JOIN US!

Visit us at booth #1249 to discover how we accelerate AAV-based gene therapies and autologous, allogeneic, and iPSC-derived cell therapies—from development through commercialization. Speak with our experts to learn how our white-glove case management services deliver end-to-end supply chain management and orchestration of advanced therapies.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Session 1
Session chair: John Tomtishen, Global Head of Field Application Scientists and Strategic Alliances, Catalent
Date/Time: Monday, May 11, 1:00 – 5:25 PM
Title: Automation in CGT manufacturing: From production to QC (separate purchase required)

Session 2
Session chair: Carey Connelly, Senior Director Process Development, Catalent
Date/Time: Tuesday, May 12, 3:30-4:00 PM
Title: Design-Intensify-Characterize-Deliver: Empower your Journey to Patients with Industry’s CDMO Leader in Commercial AAV

Session 3
Session chair: John Tomtishen, Global Head of Field Application Scientists and Strategic Alliances, Catalent
Date/Time: Wednesday, May 13, 4:00-4:30 PM
Title: Fill Finish and Cryopreservation – the Final Mile of Success for Cell Therapies

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™